Daihan Pharmaceutical Market Cap

Daihan Pharmaceutical has a market cap or net worth of 154.94 billion as of June 3, 2026. Its market cap has decreased by -2.59% in one year.

Market Cap

154.94B

Enterprise Value

56.33B

Revenue

211.44B

Ranking

n/a

PE Ratio

5.74

Stock Price

26,300.00

Market Cap Chart

Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 154.94B, an increase of 596.04%. That is a compound annual growth rate of 7.98%.

Market Cap History

Date	Market Cap	% Change
Jun 2, 2026	154.94B	-9.91%
Dec 30, 2025	171.99B	11.64%
Dec 30, 2024	154.06B	-5.59%
Dec 28, 2023	163.17B	-11.13%
Dec 29, 2022	183.60B	6.62%
Dec 30, 2021	172.20B	-12.90%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Daewon Pharmaceutical	176.18B
Hyundai Pharmaceutical	175.48B
JW Lifescience	174.20B
CMG Pharmaceutical	173.71B
HLB Pharmaceutical	163.03B
Hana Pharm	161.91B
Jeil Pharmaceutical Co.,Ltd	160.14B
Dongwha Pharm.Co.,Ltd	151.62B

Market Cap Rankings